AC
ISEE

Armistice Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Armistice Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,836,000
Closed -$44.7M – 292
2023
Q1 		$44.7M Buy
1,836,000
+44,000
+2% +$963K 0.64% 36
2022
Q4 		$38.4M Buy
1,792,000
+428,000
+31% +$9.13M 0.67% 35
2022
Q3 		$24.5M Buy
+1,364,000
New +$17.9M 0.42% 51
2018
Q2 		– Sell
-3,592,000
Closed -$9.84M – 93
2018
Q1 		$9.84M Buy
3,592,000
+142,000
+4% +$412K 0.75% 43
2017
Q4 		$10.8M Buy
3,450,000
+86,000
+3% +$242K 1.07% 32
2017
Q3 		$9.49M Buy
3,364,000
+964,000
+40% +$2.6M 1.12% 36
2017
Q2 		$6.14M Buy
+2,400,000
New +$6.54M 0.78% 43

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Armistice Capital's ISEE Position: Q2 2023 in Review

Armistice Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2023, closing a stake of 1,836,000 shares — an estimated $44.7M sold.

Armistice Capital first reported a position in ISEE in Q2 2017 and held it in 7 quarters. The position peaked at $44.7M in Q1 2023. 255 funds tracked by Wall St. Rank hold ISEE as of Q2 2023.

  • Armistice Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Armistice Capital sold 1,836,000 IVERIC bio, Inc. Common Stock shares in Q2 2023, an estimated $44.7M.
  • Armistice Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2017 and held it in 7 quarters.
  • Armistice Capital's IVERIC bio, Inc. Common Stock position peaked at $44.7M in Q1 2023.
  • 255 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2023.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.